<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"><html xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>1471-2164-7-259.fm</title>
<meta name="Author" content="csproduction"/>
<meta name="Creator" content="FrameMaker 7.0"/>
<meta name="Producer" content="Acrobat Distiller 5.0.5 (Windows)"/>
<meta name="CreationDate" content=""/>
</head>
<body>
<pre>
BMC Genomics

BioMed Central

Open Access

Research article

TasA-tasB, a new putative toxin-antitoxin (TA) system from Bacillus
thuringiensis pGI1 plasmid is a widely distributed composite
mazE-doc TA system
Sarah Fico and Jacques Mahillon*
Address: Laboratoire de Microbiologie Alimentaire et Environnementale, UniversitÃ© catholique de Louvain, Croix du Sud, 2/12, B-1348 Louvainla-Neuve, Belgium
Email: Sarah Fico - fico@mbla.ucl.ac.be; Jacques Mahillon* - mahillon@mbla.ucl.ac.be
* Corresponding author

Published: 13 October 2006
BMC Genomics 2006, 7:259

doi:10.1186/1471-2164-7-259

Received: 05 July 2006
Accepted: 13 October 2006

This article is available from: http://www.biomedcentral.com/1471-2164/7/259
Â© 2006 Fico and Mahillon; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract
Background: Post-segregational killing systems are present in a large variety of microorganisms.
When found on plasmids, they are described as addiction systems that act to maintain the plasmid
during the partitioning of the cell. The plasmid to be maintained through the generations harbours
a group of two genes, one coding for a stable toxin and the other coding for an unstable antitoxin
that inhibits the effects of the toxin. If, during cell division, the plasmid is lost, the toxin and antitoxin
proteins present in the cytosol cease to be newly expressed. The level of unstable antitoxin protein
then rapidly decreases, leaving the toxin free to act on the cellular target, leading to cell death.
Consequently, only cells harbouring the plasmid can survive.
Results: The pGI1 plasmid of Bacillus thuringiensis H1.1 harbours a group of two genes, one
showing similarities with the Doc toxin of the phd-doc toxin-antitoxin system, potentially coding for
a toxin-antitoxin system. Attempts were made to clone this putative system in the Gram-negative
host Escherichia coli. The putative antitoxin tasA was easily cloned in E. coli. However, although
several combinations of DNA fragment were used in the cloning strategy, only clones containing a
mutation in the toxin gene could be recovered, suggesting a toxic activity of TasB. An exhaustive
search was carried out in order to index genes homologous to those of the putative tasA-tasB
system among microorganisms. This study revealed the presence of this system in great number
and in a large variety of microorganisms, either as tasA-tasB homologues or in association with
toxins (or antitoxins) from other TA systems.
Conclusion: In this work, we showed that the pGI1 plasmid of B. thuringiensis H1.1 harbours genes
resembling a toxin-antitoxin system, named tasA-tasB for thuringiensis addiction system. This system
appeared to be functional but unregulated in E. coli. Bioinformatics studies showed that the tasAB
system is present on plasmids or chromosomes of a large variety of microorganisms. Moreover,
the association between TasA antitoxin with toxins other than TasB (and vice versa) revealed the
composite and modular nature of bacterial TA systems.

Page 1 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

Background
Plasmids are extrachromosomal elements that carry
mostly non-essential genes. However, they often confer
advantages to their host, because of determinants such as
antibiotic-resistance or virulence genes. When a mothercell divides, plasmids have to be partitioned into the
daughter-cells to keep for the progeny to retain this advantage. For high copy number plasmids, this process occurs
by random distribution. However, when a plasmid is
present in the cell at a low copy number, the cell has to
develop active systems in order to avoid the production of
plasmid-free progeny by loss of plasmid during partitioning. One strategy is to actively distribute the plasmid by a
mechanism that relies on the presence of centromere-like
functions [1,2].
Another strategy is the mechanism called post-segregational killing system or toxin-antitoxin (TA) system. The
plasmid to be maintained harbours a group of two genes,
one coding for a stable toxin, and the other one expressing
the antitoxin counterpart. This antitoxin is an unstable
protein that is continuously degraded by a protease. When
the plasmid is present in the cell, both toxin and antitoxin
are expressed and the antitoxin acts on the toxin to prevent its toxic effects. If, during segregation, the plasmid is
lost, toxin and antitoxin are no longer produced and the
level of antitoxin rapidly decreases in the cell, leaving the
toxin free to act on its target and leading to the death of
the cell. Only cells harbouring the plasmid do survive.
Such systems are known to be present in a wide range of
prokaryotes [3]. Although the targets of the toxins may
differ and sequence homologies may be quite low, these
systems tend to be very similar in structure and regulation
[4]. One of these systems, phd-doc, has been described in
bacteriophage P1 as an addiction operon [5]. This temperate bacteriophage is stably maintained as a plasmid
prophage in the Gram-negative bacterium Escherichia coli.
The bacteriophage harbours a group of two genes, one
coding for a toxin, doc (death on curing), and an upstream
gene coding for its antitoxin, phd (prevent host death) [5].
In host cells possessing the P1 genome, stable Doc toxin
and unstable Phd antitoxin are continuously expressed
[6]. Phd antitoxin interacts with the Doc toxin, preventing
it from carrying out its molecular action on the target,
which is unknown. It has been suggested that a trimeric
complex P2D is formed, sterically or structurally altering
the Doc toxin activity on the target by buffering free Doc
molecules within the cell [7]. Moreover, Phd is also
known to repress both its own transcription and that of
the Doc molecule by binding to an operator DNA site that
overlaps the addiction promoter [8]. It has also been suggested that the Phd antitoxin might exert its action by activating another protein that neutralizes the Doc toxin [7].
The Phd antitoxin is continuously degraded in the host

http://www.biomedcentral.com/1471-2164/7/259

cell by the ClpXP protease system [6], composed of the
ClpP protease and the regulatory ClpX ATPase subunits
[9-11]. Phd-doc is thus an active system that ensures stable
inheritance of the P1 genome in the host cell population
by killing any segregants that are free of the P1 genome.
The actual function of TA systems had to be re-examined,
however, when chromosomal TA systems were discovered. A first hypothesis proposes that chromosomal TA
systems contribute to programmed cell death (PCD) that
occurs in response to various stress signals [12-15].
Indeed, experiments carried out on the mazEF system have
shown that high levels of ppGpp, the signal molecule of
nutritional stress, repress the mazEF promoter. This
repression leads to the drop of MazE antitoxin levels and
subsequently to the death of the cell [16]. By the same
mechanism, antibiotics inhibiting transcription, such as
rifampicin, or translation, such as chloramphenicol and
spectinomycin, have been shown to induce PCD via the
activation of the mazEF system [17]. A second hypothesis
suggests that, rather than activating programmed cell
death, chromosomal TA systems may induce a reversible
bacteriostatic state to protect the cell in response to stressful conditions [3]. Indeed, it was shown that the induction of the antitoxin MazE after exposition to
overproduction of the toxin MazF restored the viability of
the cell, suggesting that the toxin MazF is bacteriostatic
rather than bacteriocide.
Bacillus thuringiensis H1.1 is a member of the Bacillus
cereus group of Gram-positive bacteria. This bacterium
occurs naturally in soil and on plants and is considered to
be harmless to human. During sporulation, it produces Î´endotoxins that are toxic to insects. B. thuringiensis strain
H1.1 contains at least four large plasmids (> 30 kb) and
three small plasmids: pGI1, pGI2, pGI3 [18]. The complete sequences of pGI2, pGI3 and pGI1 plasmids have
been determined [18-20]. Based on the analysis of the
8254 bp pGI1 plasmid, five ORFs larger than 100 aa in
size have been identified [18]: a rep gene encoding the Rep
protein, which is responsible for the autonomous replication of the plasmid, a mob gene that enables mobilization
of the plasmid, and ORF5, which is a putative transcriptional regulator. Another ORF, downstream of the mob
gene, encodes a 133-residue protein and shows a high
degree of similarity to the Doc toxin of the P1 bacteriophage. The last ORF (95 aa) located upstream of the
putative toxin gene could potentially code for the antitoxin counterpart.

Results and discussion
TasB of pGI1 from B. thuringiensis H1.1 is toxic in E. coli
pGI1, the smallest plasmid of B. thuringiensis H1.1, harbours a pair of ORFs that are predicted to encode 95 and
133 residue proteins, respectively (Fig. 1). The second of

Page 2 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

these putative proteins displayed sequence similarities
(28% identity; E-value = 2e-19 in the Conserved Domain
Database) with the Doc toxin of the toxin-antitoxin system phd-doc from phage P1. The upstream gene could
therefore code for the corresponding antitoxin. This gene
pair was tentatively named tasAB for thuringiensis addiction system.
TasB, the putative toxin component of this TA system
(fragment P, Table 2) was cloned into the positive-selection vector pCR4-TOPO (KanR, AmpR). After electroporation into E. coli TOP10, only a few colonies were able to
grow on LB + Kan medium. Sequencing these recombinants showed that they all harboured a mutation in the
toxin gene (see details below).
Since it was found to be impossible to clone the tasB toxin
gene alone in E. coli, a PCR fragment (AP) spanning the
full sequence of both genes from the start codon of the
antitoxin tasA to the stop codon of the toxin tasB was
inserted into pCR4-TOPO and transformed into E. coli.
However, as for tasB alone (P fragment), all the recombinant clones contained mutations in the tasB toxin gene.
An alternative was to clone the tasAB cluster with its own
promoter region into E. coli. Two constructions were
tested: pAP, containing a region of 232 bp upstream of the
start codon of antitoxin tasA, and p2AP, containing an
upstream region of 311 bp. Once again, only recombinants possessing a mutation in the toxin gene tasB could
be recovered on selective plates.
In order to avoid the killing effect of the TasB toxin, an E.
coli strain expressing the TasA antitoxin was constructed as
follows: the pGI1 tasA antitoxin gene was inserted into the
positive-selection vector pCR4-TOPO and electroporated
in E. coli TOP10, leading to the construct pGIF02 (see
Material and Methods). The tasA antitoxin gene was then
inserted into the pCYB10 vector downstream of the IPTGinducible promoter ptac and electroporated into E. coli
TOP10. Sequencing confirmed the absence of any mutation in the antitoxin gene. The newly constructed vector
was named pGIF03. The A, P, AP, pAP and p2AP fragments inserted into vector pCR4-TOPO (see Fig. 1 and
Table 2) were then electroporated into the E. coli TG1/
pGIF03 strain, in the presence of 1 mM of IPTG to induce
expression of the antitoxin. Once more, no recombinants
harbouring the wild-type tasB toxin gene were obtained
from the P-, AP-, pAP- and p2AP-containing constructions.
As indicated above, all the recombinant P, AP, pAP and
p2AP fragments in E. coli harboured mutations in the tasB
toxin gene. In many cases, the mutation was an early stop
codon (Fig. 3). The longest toxin protein obtained in E.

http://www.biomedcentral.com/1471-2164/7/259

coli lacked the last 21 amino acids. In other cases, a point
mutation leading to the modification of only one amino
acid appeared to be sufficient to inactivate the TasB protein. These point mutations were found in all part of the
protein but it is interesting to note that four of them (D28,
L72, A79 and V80) were found in particularly well conserved regions of the protein TasB. Finally, one case of an
IS1 insertion in the tasB gene was also observed (not
shown). All these mutations are reported in the pile-up
showing tasB and its homologues found in other bacterial
genomes (see below) (Fig. 3).
These cloning experiments strongly indicated a toxic effect
of TasB when cloned into E. coli. This supports the proposal that the pGI1 plasmid of B. thuringiensis H1.1
encodes a new putative toxin-antitoxin system. However,
this system appeared to be functional but unregulated in
E. coli. Indeed, the addition of a plasmid containing the
tasA gene failed to inhibit the lethal activity of TasB in E.
coli. This may be explained by an inappropriate expression
of the antitoxin in the Gram-negative background. TA systems are regulated at transcriptional level by the antitoxin
and/or the antitoxin-toxin complex, and this antitoxin is
continuously degraded by a specific protease present in
the cytosol of the bacterium. It has been shown that the
toxin/antitoxin stoichiometry influences the binding of
the complex to the promoter-operator region [21]. When
cloned into E. coli, the tasA-tasB system might be misregulated by a change in the TasA/TasB ratio, as a consequence
of its dependence on a different system of proteases than
in the host B. thuringiensis. Experiments are currently
underway to determine the TasA level in this bacterium.
Homologues of the tasA-tasB genes of pGI1 reveal the
existence of combinatory TA systems in a large variety of
microorganisms
Homologues of tasA-tasB from pGI1 are found in a large variety of
microorganisms
The amino acid sequence of the TasB toxin was compared
to bacterial protein databases. The genomic location of
each toxin homologue was analyzed individually in order
to identify any immediately upstream ORF as putative
antitoxin. Because antitoxins are often very small proteins,
they were not always annotated in the databank. In most
cases, a small ORF was indeed present directly upstream
of the TasB homologue (Fig. 4).

In 55 cases, the ORF found upstream of the TasB homologue displayed significant similarity to the TasA antitoxin
of pGI1. These loci were found in a large variety of microorganism including 14 firmicutes, 26 proteobacteria, 6
chlorobi, 4 cyanobacteria, 2 chlamydiae, 1 acidobacterium, 1 bacteroidete and even 1 planctomycete (see Additional file 2). In this group, all putative antitoxin proteins
had about the same size as TasA. Almost all members in

Page 3 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

http://www.biomedcentral.com/1471-2164/7/259

A.

ORF133
Putative ORF95
Putative
toxin
antitoxin

ORF94
(94 a.a.)

0

ORF182
(182 a.a.)

1K

u
do

mo
b1

8K

7K

b le

nd
-st ra
ori g i n (dso)

2K

3K

rep
1

6K

)
si n g l e -stra n d o ri g i n (sso

pGI1 (8254 bp)

ORF5
Hypothetical
transcriptional
regulator

5K

4K

ORF71
(71 a.a.)

ORF88
(88 a.a.)

B.

Antitoxin
DOTF
DOTF

A

DOTR2
DOTR2

poif
pOIf

P
DOTF
DOTF

AP
ValC
ValC

pAP

ValC2

ValC2

p2AP

Toxin

DOTR2
poif

pOIr

pOIr
poir
poir
pOIr

poif

pOIr

poif

poir

pOIr

Figure 1
Organization of toxin and antitoxin genes frompGI1 of B. thuringiensis H1.1
Organization of toxin and antitoxin genes frompGI1 of B. thuringiensis H1.1. A) pGI1 contains a mobilization gene
(mob1), a replication gene (rep1), a hypothetical transcriptional regulator (ORF5), three small cryptic ORFs (URF94, URF71,
URF88) and the putative toxin-antitoxin system tasB and tasA. TasB displays similarities with the Doc toxin of bacteriophage
P1. The upstream ORF, tasA, could code for the antitoxin counterpart. Putative double- and single-strand origins are also indicated. B) To assess the function of tasA and tasB, different parts of this putative toxin-antitoxin system have been amplified for
cloning purposes. This figure is a scaled representation of the primers and amplimers used in cloning experiments (See Table 2
for details). Amplimer names are shown in the left column.

Page 4 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

http://www.biomedcentral.com/1471-2164/7/259

10

20

30

40

60

50

70

80

- - - - - - - M T A N T R HME T QK I E R K V T K I GN S L G L T L P QE F Y T T L N I K QGD V V S L E I N E E N E Q I V I K K S K K
- - - - - - - - - - - - - - - - - - - M S F K V H P WG N S S A V P V P S H V R K V L G I E N G S E V E I E V K D G A M I V K P V K K - - - - - - - - - - - - - - - - - M N I K K R K I R E V G N S I V V T L S K E S L L Q K G L K P G D - - - T I F I D E D K MM D A I V K - - - - - - - - - - - - - - - - MK KMK K Y K I R K S GN S D V T T I P P E V K E F MG V Q T GD A I S Y V F Q S D G S V RM I K A Q - - - - - - - - - - - - - - - - - ME I K E R K L R K V GN S V VM T L S K E F L E S I GA T A T D - - T V Y V D E E K L K D I I V K K N - - - - - - - - - - - - - - - - - - - MV V K T R K QGN S I T I T I P S E F N I P S GV K Y E A K L L P S GE I I F T P E E L GQQ - - - M K K K W T R K C WE A R M T K R I H A R I S Q V G N S L S V S I P K D L A T M L N L N K G D E I E I Y Y D K E R G E I V M K R A N - - - - - - - - - - - - M E G L QM I T T R K L R K A G N S S V V S V P T E V I A A L G I S N G D N L K F N V K D N K V T I E K E V R - - - - - - - - - - - - - - - - - - - - MV V K T R K QGN S I T I T I P S E F N I P S GV K Y E A K L L P S GE I I F T P E E L GQQ - - - - - - - - - - - - - - - - MD D V L Y K K V V K N G S S L A I N I P V K E V Q K QN I K A GD I V E V K I K K A H Q V K Q E - - - - - - - - - - - - - - - - - - - - - - MQ V K H L V QH GN S K A I V I D K S I L Q A A G L D E N C L F Q I V V D S N T G V T I Q S V K - - - - - - - - - - - - - - - - - - - MR S I K L R K V GN S F G F T I P K E L I E K Y N L K E G E - - E L H V I E MS E G - F T L T P - - - - - - - - - - - - - - - - - - - - MK L K I T A I GN S A G V I L P K E L L A R L R L G K GD - - E L Y A L E T P D G - I K L T A - - - - - - - - - - - - - - - - - - - MQ V K H L V QH GN S K A I V I D K S I L Q A A G L D E N C L F Q I V V D S N T G V T I Q S V K - - - - - - - - - - - - - - - - - - - - MK L K I T A I GN S A G I I L P K E L L A R L R L G K GD - - E L Y A L E T P D G - I R L T A - - - - - - - - - - - - - - - - - - - MS T L K L R K I GN S Y G V I L P K E V I S R L K V E E GD - - S V Y I T E S H D G - Y N I S S - - - - - - - - - - - - - - - - - - - MK T T R L R K V GN S Y G F T I P K E L MD K Y N L N E G V - - E L N I I E QN D G - F A L T P - - - - - - - - - - - - - - - - - - - - MN V T I R K I GN S E G V I L P K E L L D R H N L K T GD A L A I V E E G S D L V L K P - - - - - - - - - - - - - - - - - - - - - - - MR A T V T K I GN S T G V I L P K A V A E R L K I K QGD - - I L Y L T E T P S G - Y A V T P - - - - - - - - - - - - - M D F L K D N K T A K V F K A G N S E A I R L T K Q D T A I F K V K P G D - - Q V I K E V S P D GM S I T F K - - - - - - - - - - - - - - - - - - - MV E L K V R K L GN S L G V V L P K E V I N H L R T GD GQ - - R L F L T E A S D GGY L I T P - - - - - - - - - - - - - - - - - - - - MN I T L R K I GD S Y G V I I P K E V L E R L N L Q T GD T L T L T T D E N G L R L A R S T E - - - - - - - - - - - - - - - - - - - - MN I T L R K I GN S Y G V I I P K E V L E R L N L Q T GD T L T L T T D E N G L R L A R S T E - - - - - - - - - - - - - - - - - - - - MN I T L R K I GN S Y G V I I P K E V L E R L N L Q T GD T L T L T T D E N G L R L A R S T E - - - - - - - - - - - - - - - - - - - - MR A T V T K I GN S T G V I L P K A V A E R L K I R QGD - - I V Y L T E T P S G - Y A V T P - - - - M S P F C Y N I WY N K M G D I M R A T V T K I G N S T G V I L P K A A A D R L K V K Q G D - - F V F L T E T P T G - Y T V T P - - - - - - - - - - - - - - - - - - - - M L K K L T K H GN S L A L V I D R P I L D L L K I D T E T P L D I S T D G T R L I V A P A A G - - - - - - - - - - - - - - - - - - - ME T L R L R K I K N - - - K L I P S SQS L K F RH S KNG - - - V L F V V KH SHN P QT T P - - - - - - - - - - - - - - - - - - - - MR A T V T K I GN S T G V I L P K A A T D R L K V K QGD - - I V F L T E T P T G - Y T V T P - - - - - - - - - - - - - - - - - - - - MK L K I T A I GN S A G V I L P K E L L A R L R L G K GD - - E L Y A L E T P D G - I K L T A - - - - - - - - - - - - - - - - - - - - MK L K I T A I GN S A G V I L P K E L L A R L R L G K GD - - E L Y A L E T P D G - I K L T A - - - - - - - MN E S P K E L K P D S S V V L Q V R K I GN S I G L I L P K EM V A R L N L K E GD - - K L F P V E Q P GGG I M L T P - - - - - - - - - - - - - - - - - - - MV V L K L G K I GN S V GA V L P K E V L V R L K V E QGD - - T L Y L T E T P D G - Y H L T P - - - - - - - - - - - - - - - - - - - M I E L K V R K F GN S L G I V L P K E V V N H L R T GD GQ - - R L F L T E A S D GR Y L I T P - - - - - - - - - - - - - - - - - - - - M K I E I K K I GN S D G L L L P K E L MQR L D L K R GQ E L H I T E L A GG G F Q AM P - - - - - - - - - - - - - - - - - - - - - MH I L K L T Q I GN S V G V V L P K E A L A R L K L G K G E - - T V F L T E T P D G - Y T L T P - - - - - - - - - - - - - - - - - - - M T T L K L S Q I GN S V GV I L P K E L L A R L H L E K GD - - V V F M T D T V N G - F T I S P - - - - - - - - - - - - - - - - - - - - MR K K L S A I GN S L G I V I E K P I L E L L D I D R E T E L DMR T D G E R L I I E P I R - - - - MR I E F Q P A Q F R A P QR L I M K I E I K K I GN S D G L L L P K E L MQR L D L K R GQ E L H I T E L A GG G F Q AM P - - - - - - - - - - - - - - - - - - - - - M L T F K V T T V GA S A GV I L T K E A L A R L K V QK GD - - T L Y L T E A P D GGY R L T A - - - - - - - - - - - - - - - - - - - - MV K Q L T K H GN SMAMV I D K P I L E L I GA D A D T P F E I T T D GQA L I L T P L K N - - - - - - - - - - - - - - - - - - - - M L K N L V P H GN S A A L I I D K P I L E I L K V DMN T P L E I T T D GK N L I I S P V H D - - - - - - - - - - - - - - - - - - - M L T F K V T T V GA S A G F I L T K E AMA R L K V QK GD - - T V Y L T E A P E GGY R I T P - - - - - - - - - - - - - - - - - - - - MR A T V S K I GN S T GV I L P K A A V E R L K V K P GD - - V V Y L T E T S T G - Y T V T P - - - - - - - - - - - - - - - - - - MP E E T T I R R I GN S S G L T I P K D L L D R QH L E E GD - - Q V H L V E T E D G - L L I T P - - - - - - - - - - - - - - - - - - - ME T V V V R K QGN S V GV T L P A E T R I R L G L E V GQE L T L V EMA D G I K L V K R - - - A V K G A V R Y N V C S N V WS A A M I A L K L S Q I G N S V G V V L P K E A L V K L G V E K G D - - T L Y L T D A P G G GM Q I A P - - - - - - - - MN E A T R D L E V E A T A L Q I R K I GN S V G V I L P K E L L A R L N L K E GD - - K F Y P V E Q P D G S L R L S P - - - - - - - - - - - - - - - - - - - - M I K T L T A H GN S S A L I I D K A I L E L L N I N N T T P L K L V T D GK S L I I S P L R E - S P V S T H L D L T H C I H R R I SM I E T K I R K V GN S A V V T L S S EM L A V L D A K P GD - - A L F V T R S D D GA L K L MA - - - - - - - - - - - - - - - - - - - - ME A K V R R V GN S L G L T L T K E A L E L L N V QE GD - - T L H L V K A R GG - L L L T R - - - - - - - - - - - - - - - - - - MG I E V R L R R A GG S V S A T I P A E MA R R F H L S P GD - - R V Q A I E T E QG - I L L S P - - - - - - - - - - - - - - - - - - - M I E T K I R K V GN S A VM T L T T EM L T I L D A K E GD - - T L F V V R GD D GS L K I T P - - - - - - - - - - - - - - - - - - - M F E T K I R K V GN S S VM T L S A E L L A I L D A K E GD - - S L F V V R GD D GS L K I MA - - - - - - - - - - - - - - - - - - - M F E T K I R K V GN S A VM T L S A E L L A I L D A K E GD - - T V F V V R GD D GS L K I M T - - - - - - - - - - - - - - - - - - - - - MR K T F K V G N S L V V S I P Q E Y V K S L G I K E G D P L I I E PWE H G F I V K T F G A V G

Bacillus thuringiensis H1.1
Bacillus clausii KSM-K16 (1)
Enterococcus faecium DO (1)
Enterococcus faecium DO (2)
Enterococcus faecalis V583
Streptococcus pneumoniae TIGR4 (1)
Geobacillus kaustophilus HTA426 (1)
Staphylococcus epidermidis RP62A
Streptococcus pneumoniae TIGR4 (2)
Lactobacillus acidophilus NCFM
Parachlamydia sp. UWE25 (1)
Halothermothrix orenii H 168
Xanthomonas axonopodis citri 306 (1)
Parachlamydia sp. UWE25 (2)
Xanthomonas campestris vesicatoria 85-10
Crocosphaera watsonii WH 8501
Alkaliphilus metalliredigenes QYMF
Mesorhizobium sp. BNC1
Prosthecochloris aestuarii DSM 271
Lactobacillus gasseri ATCC 33323 (1)
Nitrosomonas europaea ATCC 19718 (1)
Brucella melitensis 16M
Brucella abortus 1 str. 9-941
Brucella suis 1330
Chlorobium phaeobacteroides BS1
Pelodictyon phaeoclathratiforme BU-1
Solibacter usitatus Ellin6076
Nostoc punctiforme PCC 73102
Chlorobium phaeobacteroides DSM 266
Xanthomonas oryzae KACC10331
Xanthomonas oryzae MAFF 311018
Bradyrhizobium sp. BTAi1
Xanthobacter autotrophicus Py2
Nitrosomonas europaea ATCC 19718 (2)
Rhodopseudomonas palustris BisB18
Polaromonas naphthalenivorans CJ2
Rhodoferax ferrireducens DSM 15236
Anaeromyxobacter dehalogenans 2CP-C
Rhodopseudomonas palustris HaA2
Rhodospirillum rubrum ATCC 11170
Chlorobium tepidum TLS
Candidatus kuenenia stuttgartiensis
Burkholderia thailandensis E264
Chlorobium limicola DSM 245
Salinibacter ruber DSM 13855
Gluconobacter oxydans 621H plasmid pGOX2 (1)
Caulobacter crescentus CB15
Rhodopseudomonas palustris BisB5
Syntrophomonas wolfei Goettingen (1)
Jannaschia sp. CCS1
Gloeobacter violaceus PCC 7421
Synechococcus sp. RS9917 (1)
Oceanicola batensis HTCC2597
Rhodobacter sphaeroides ATCC 17025 (1)
Rhodobacter sphaeroides ATCC 17025 (2)
Carboxydothermus hydrogenoformans Z-2901 (1)

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - MR E R A L
- - - - - - - - - - MAR S T L
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Consensus

- - - - - - - - - - - - - - - - - - - - - - - -

k

k

gn s

g

l p ke

l

l

gd - -

g

I
-

90

100

SMP ED L N P K F L E S L NR T I N K F DGA F KD L VNR
- - D EGVDQA F I D F L K K T D K K F E T V T RN L VDR
- E E S N L D L E I DMY V NQA L S E Y D A A F K E L V D R
- - - - - E E P D I D S L V D S I MN Q Y E D A L K D L V D L
- - M S E H Q K K L Q QMM E N S K Q K H N E L Y K E L V T K
- V SYV SDDA FD L N L DK I FDE YDDV F KA L VE K
R I P K G V R P E V VMAMN R A I S K Y D E A L R N L K Y R
- - - - - E D E E F F K L L D E T F T E Y NQA L K RMV D L
- V SYV SDDA FD L N L DK I FDE YDDV F KA L VE K
- - - - - D M H E I D G - - - - L I S D Y WD M L E Y L K D K
- - - PVNSK F EEA - KKYV FNEYAE L F KR L SDR
- F D P E F E NWA S A - F E K T N K K F K N T L R E L S K - F D P T L A A QM D V - A E Q V M R E D R Q V L N K L A K - - - PVNSK F EEA - KKYV FNEYAE L F KR L SDR
- F D P T L A A QM D V - A E Q V M R E D R Q V L N K L A K - F D PD F E E TMK A - F ED T Y RQYRN A F K E L A K - Y D P E F D KWV N S - F D K T N K K Y K N T L K A L S K - V D D A F E R Q L K A - A H E I MD Q Y K V A L QK L A E - Y D P E F A E QM E A - A R Q GM S K Y K N A L H E L A K - KMP E V S ED V K K E V SD I L N E D AD L I QA L KD L
- Y D P A F E E KMV K - V EN I CDR YRN T L R I L A K - D A E V L E K K MQ I - A R E RM K K Y E T A Y R V L A Q - D A E V L E K K MQ I - A R E RM K K Y E T A Y R V L A Q - D A E V L E K K MQ I - A R E RM K K Y E T A Y R V L A Q - Y D P E F A E Q I E A - A R E GM S E Y R N A L H E L A K - Y D P E F A A QM E A - A R R GM T E Y R N A L H E L A K - P Q A R R K K F D A A - Q EWA H K R Y G K T F E R L A K - D K S E F E K AME A - Y QK V S S K YRN A L R E L AQ - Y D P E F A K QM E A - A R C GM K E Y R N A L H E L A K - F D P T L A A QM D V - A E Q V M R E R R T L L N K L G Q - F D P T L A A QM D V - A E Q V M R E R R T L L N K L G Q - H D P D F E R A M T V - A R R GM K R Y H N A L S E L A K - Y E P E F E A QM E E - A R K I M K K R R N V L R E L A K - YD P S F GE KMA K - V E D I CNR YRN T L H V L T K - YD P D F ER TME I - ADQ I ME K Y K D T L A A L A K - Y D P A L E E E I T A - GR A F MR D F R D T F H Q L A K - Y D P T F D E QM T Q - A R S I M K K R R A V L H E L A K - - S A RR A K V K A A - T HR AMA AHD A T L R K L A K - YD P D F ER TME I - AD E VME K Y K D T L A A L A K - C D P D F E R QM A L - A E E I M H D D R D I L R A L A K - - P K GGE A F GV A - L E K V N T R Y A R A L K K L A E - - KDRDKK FRA A - L V K I NKKHE K T L KK L A E - Y N P D F E R QM K L - A E E I M H D D R D I L R A L A K - Y D P E F E A QM E A - A R R GM T E Y R N A L H E L A K - Y D P D F E D AME A - Y E GGA R D Y R N A L R A L S D Q
- - N L R L E R QM QM - A R E T L R E Q A N V L Q E L A K R
- Y D P D V A R Q I A L - GE E I MD E Y R D T F R A L A K - F N P K H A R TME I - A R QVMH E Y R D T L A A L A K - - P F R E E K F K A A - L K K V N A N H GD T L QK L GE - H D P E L QA A L A A - A E E VMD E N R D L L QA L A - - C D P Q F A R AMQ A - Y K L A S R E Y H D A L N E L A Q - FDP A V E E A L A L - A S A A ARQFQP A L RE L AR - QD P A V A A A L A A - A E I VMD E N R D L L QA L A - - H D P S V V A A L E A - A E I VMD E N R T L L A A L A - - H D P S V A A A L E A - A E I VMD E N R S L L A A L A - - - K E S K I P SGK S P V E K L L E K YGF V V E E F S S -

- - - -

dp

-

m

y

l

l a

-

Figure antitoxins members of the TasAB family
Putative 2
Putative antitoxins members of the TasAB family. Multiple alignments of the putative antitoxins related to the TasA
antitoxin of pGI1. Only TasA-like proteins with obvious downstream TasB-like partners (see Fig. 4) were included in this comparison. The most conserved amino acids (>50%) are in grey. The names of the bacterial strains where these loci were found
are indicated in the left column. The consensus sequence is displayed in the last line.

this group displayed a gene organization found in many
TA systems in which the stop codon of the antitoxin overlaps the start codon of the toxin. This was however not the
case for those found in Bacillus clausii, Geobacillus kaustophilus, Lactobacillus acidophilus, Lactobacillus gasseri, Nitrosomonas
europaea,
Rhodospirillum
rubrum,
Rhodopseudomonas palustris BisB5 and HaA2, Salinibacter
rubber, Xhanthomonas oryzae KACC10331 and MAFF
311018, Xhanthomonas campestris vesicatoria and Gloeobacter violaceus (see Additional file 2). In this group, all the
TasB homologues were found on the chromosome of the
bacteria, except for Glucunobacter oxydans 621H in which
the corresponding locus is found on the plasmid pGOX2
(see Additional file 2).
The 55 TasB homologues found in this group were aligned
(Fig. 3). The pile-up showed a particularly well conserved
region, with the motif H(x)5NKR(x)8F(x)3N. The 55 TasA

homologues found upstream of the TasB homologues
were also aligned (Fig. 2). It was interesting to observe
that the end of the protein is particularly well conserved
in all species, with a well conserved C-terminal domain.
The GNS motif on the N-terminal part of the protein was
also very well conserved among the organisms of this
group.
These 55 loci displaying similarities with both TasA and
TasB were grouped into a family named the TasAB family
(Fig. 4 and Additional file 2). To our knowledge, the tasAB
system is the first described in this novel family.
TasB homologues can be associated with putative antitoxins
unrelated to TasA
In addition to the loci described above, the bioinformatic
analysis provided 62 more TasB homologues (E value < 1)
that were associated with upstream genes unrelated to the

Page 5 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

30

Mutants found in E. coli recombinants
Bacillus thuringiensis H1.1
Bacillus clausii KSM-K16
Enterococcus faecium DO (1)
Enterococcus faecium DO (2)
Enterococcus faecalis V583
Streptococcus pneumoniae TIGR4 (1)
Geobacillus kaustophilus HTA426 (1)
Staphylococcus epidermidis RP62A
Streptococcus pneumoniae TIGR4 (2)
Lactobacillus acidophilus NCFM
Parachlamydia sp. UWE25 (1)
Halothermothrix orenii H 168
Xanthomonas axonopodis citri 306 (1)
Parachlamydia sp. UWE25 (2)
Xanthomonas campestris vesicatoria 85-10
Crocosphaera watsonii WH 8501
Alkaliphilus metalliredigenes QYMF
Mesorhizobium sp. BNC1
Prosthecochloris aestuarii DSM 271
Lactobacillus gasseri ATCC 33323 (1)
Nitrosomonas europaea ATCC 19718 (1)
Brucella melitensis 16M
Brucella abortus 1 str. 9-941
Brucella suis 1330
Chlorobium phaeobacteroides BS1
Pelodictyon phaeoclathratiforme BU-1
Solibacter usitatus Ellin6076
Nostoc punctiforme PCC 73102
Chlorobium phaeobacteroides DSM 266
Xanthomonas oryzae KACC10331
Xanthomonas oryzae MAFF 311018
Bradyrhizobium sp. BTAi1
Xanthobacter autotrophicus Py2
Nitrosomonas europaea ATCC 19718 (2)
Rhodopseudomonas palustris BisB18
Polaromonas naphthalenivorans CJ2
Rhodoferax ferrireducens DSM 15236
Anaeromyxobacter dehalogenans 2CP-C
Rhodopseudomonas palustris HaA2
Rhodospirillum rubrum ATCC 11170
Chlorobium tepidum TLS
Candidatus Kuenenia stuttgartiensis
Burkholderia thailandensis E264
Chlorobium limicola DSM 245
Salinibacter ruber DSM 13855
Gluconobacter oxydans 621H plasmid pGOX2 (1)
Caulobacter crescentus CB15
Rhodopseudomonas palustris BisB5
Syntrophomonas wolfei Goettingen (1)
Jannaschia sp. CCS1
Gloeobacter violaceus PCC 7421
Synechococcus sp. RS9917 (1)
Oceanicola batensis HTCC2597
Rhodobacter sphaeroides ATCC 17025 (1)
Rhodobacter sphaeroides ATCC 17025 (2)
Carboxydothermus hydrogenoformans Z-2901 (1)
Consensus

http://www.biomedcentral.com/1471-2164/7/259

40

50

- 30 - - - - - - - - - 40 P - - - - - - - - 50 I
I T E T QA I F I N E T L I DMY S PN EQR
P S VQE V I R I NHY V I MK Y S PDEQ I
L SERD I VK LNV I Q I KRYSPKE T I
L S T K E I I K I N A K V I L RH S PGEM I
L S A D D L F QMN T F L I Q T Y S P A E Q I
L T E KQ I E K I N A L A I QR Y S PN E K I
L T A E E I I F I H Y T I MEMYDD A EQA
L T E KQV I A I N V K A I QD F S P K EQV
L T E KQ I E K I N A L A I QR Y S PN E K I
L S E VD I L T I N AR I I QR EGE KHQV
L S V E E V I L I HDH L V S A YGG L H - I P K K V I L Y F YDQ L L Q T YGGKH - V T H A L A L A I H ERQ L S EHGGA S - L S V E E V I L I HDH L V S E YGG L H - I T H A L A L A I H ERQ L S EHGGA S - L S E K A I R A I Y E A L I SR T GG T F - I P KD I I L Y SHDQ L I Q L YGGS S - L S R L V I E AMH E E Q L R R H GGA R - L L EGV V L G I HD EQ I A EHGGS T - L SSSD L I YVNKRV L E F TGEKQE I DEQVA L A I HER L I S L HSGAS - H SR V F I E A L HQEQ L R L HGGA T - H SR V F I E A L HQEQ L R L HGGA T - H SR V F I E A L HQEQ L R L HGGA T - I L D E V V L A I HD EQ I A EHGGS T - L L DGV V I A I HD EQ I A EHGGS P - F P SD E V L E I H EQQ I DR YGGS S - L S E A V I K AMH E E Q L A E H GG L P - L L D E V V I A I HD EQ I A VHGGS L - - - - - - - MA I HDRQ L A EHGGGS - I ER P L V L A I HDRQ L A EHGGGS - L T R QM V V A I H D E Q L A I H GG A S - V T K A V V L A VHD AQ L A EHGGGR - I N EQD V L A I H ER L I F L HGGA S - I T F EQA I A I H SRQ L RR F GGA P - V S K S S L L L L HGE S L A EHGGA T - I E S A L I H A VHD EQ L A EHGGG T - L D L DD V L L I H E EQ L A T YGGA V - I T Y E QA I AMH A R Q L R R F GGA P - VG L K T V Y A VHDRQ L A EHGG L D - L D L H E V L H I HRDQ I T R YGG T L - L T L A E V I D I H S N QMR L Y GG L P - VR AD L T Y A I HDRQ L A EHGG L D - L L EGV VMA I HD EQ I A EHGG I T - GS P E K V A A I HDD P L KQHGG L P - L E P D A V L FMH D QA L K E Y GG T H - VR I E A L K V L H ER S L A L HGGP S - L D I D E V I DMH A E Q L SM F GGP E - L S I GE V V E I HRDQV ER YGGH P - V P VQ T L Y V VHDRQ I ARHGGA P - L P E N A V E AMH L S T L A D F GG L S - V P S V A V E A I HRQQ T L EHGG L Q - V P L A A V I A I HDRQ I T RHGGA S - V P L A A V F V I HDRQ I ARHGGGA - V P L A A I F A I HDRQ I ARHGGK S - - - MMN L K E C L N A Y Y R Y Y G E E K - a i h

q

h g g

60

70

- D - - - - - - 60 - - - T - - - L - 70 - - - - - - - - GV KD T G L L QS A I YR PQQ T V AQED A Y P
- GV K EMN L L E S A L H R P K QS V L GK D A Y P
- GV I D KN A L SMA VNQP KQH I F GKD L Y P
- GV KD AN A L DMA V KQP SQA V FNQE L Y P
- G I KDRN A L EMA SNQP AQF V FD VD L Y P
- Q T V S P S A L NM I VN L P EQ F V FGK P L Y P
- G I Q F P D K F A WM L E R P K T K L F G E E Q F P
- GV K V P E V L N A T I EGV KQS F GGV E L Y E
- Q T V S P S A L NM I VN L P EQ F V FGK P L Y P
SH VRD A E A L H F L I EQP KQ I S F GQE L Y P
- G I R DMG L L V S A I EMP K T TM F GE Y L H E
- G I RDEK L L DSA L EQPKA TYEGKY L HD
- GVRD E A L L D S A L AR PQQ L F S YGD P P P
- G I R DMG L L V S A I EMP K T TM F GE Y L H E
- GVRD E A L L A S A L AR PQQ L F S YGD P P P
- G I L N E GM L E S T L N K P K N T Y C Y E N N P S
- G I RD I K L L E S A L EQP K A T F GG T Y L HD
- G I RDANA L ESA L ARP - ENK L AYG - DP
- G I RD AG L L S S A L AR P - QHQAH F DND P
- V I Q Y P E G L S V I I E Q P QM V L F GH E L Y P
- GVRD K E L L K S A L AR P L N L L A YDQQA - G I RD S S L L D S A L AR A - QH K E A YG - N P
- G I RD S S L L D S A L AR A - QH K E A YG - N P
- G I RD S S L L D S A L AR A - QH K E A YG - N P
- G I RD A S L L S S A L AR P - QNQAQY SDD P
- G I RD VG L L S S A L AR P - QNQAN YG - E P
- G I RD PGG L QS A L A T PQA T F DGE F L H P
- G I RDRN L F L AS LDRPKN L FAYG - - - - G I RDSGL L YSA L ARP - KHKANYG - DP
- GVRDD A L L D S A L AR P KQ L S A YGD P S P
- GVRDD A L L D S A L AR P KQ L S A YGD P S P
- G L R D E GM L E S A L D R P R N KWA Y E G A E - GVRD E A L L E T A L DR P KNR YH Y L QQD E
- G I RDRN L L K S A L AR P L N F S V YDQQS - G L R D E G M L R S A L E R P V N K WR Y E Q S E - G L RN EG L L D S A L GR P L N L L A Y A SQD - GVRDHN L L E S A L AR PQQ L AH YGS PD E
- G I RD VG L L E S A V AMPR A S AGGE L AH E
- G L R D E G M L R S A L E R P I N K WR Y E S S D - G L RDQGA V E S A L AR PRNR A A YN S - - - GV R DMG L L T S A I AMP T AM F K GD F L H T
- G I RD I N L L S S A I AMPH A S FHGE Y L HN
- GVRD KGA V E S A L AR PQN L D V Y A S - - - GVRDAV L L FSA L ERP - KNQAHYG - KP
- GARD EGA V E S A L AR P KH L Q T YGDD - - G L K S E D L L H S A L A R A E N R WH Y A E S D - GVRDEGL L ESA L ERPKNR FHYEG - - - G L R D R G M L E S A L M R P V N QWH Y G E V D - G I RDND L L CSAVAGPEA T FSGKY L NV
- GVRD I AR L A TACAP - - - TQSHGASD - GVRDEAA L QAS L ARPRHRRHYNP - - - G L R S Q A A L D A A L A R P QQRWS Y G E L R T
- GMR D R A L L E MGC A R A L N L A A Y T D A R - G L R D R A L L E S GC S R P L N L WA Y G S P S - G L R D R D L L A S G S A R P V D L WS C G T P T L MA VN VD A L D K A L A E P Y A K T F I GGR E I

- - - g

r d

l l

s a l a r p

90

80

- 80 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - AGQER
- - - - - - - - - - - - AD - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - YP - - -

I
-

100

110

120

100
110
120
- - - - - 90 - E - - - - - - - - - - - - - L - - - - - - A V - - - - - - - - T I FH K A T A L F E S L A KNH A F YN AN KR T A L AC L EM
- - - T I Y E K A A A L F Q S L V QN H C F Y N A N K R T A L WS V E Y
- - - DV FSKAAV L L I N L I KKHP FHNANKR TA F L AAY I
- - - E I Y E K A A I L A I N L A K KH P F HNGN KR T A L V AM L L
- - - T I E E K A A I LM I N I A T KHC F YN AN KR T A VMA TD L
- - - T I FDKA T I L FVQL I KKHV FANANKRTA F FV L VK
- - - S I I E K ACC Y YH S I A T GH I F HNGN KR T A L T V F V T
- - - T I ER K A A F I YRN I AQKH A FHN AN KR T A F T SMV I
- - - T I FDKA T I L FVQL I KKHV FANANKRTA F FV L VK
- - - T FSSKAG I L L I K L I KKHV FDDANKR TA T I A F L L
- - - S I F D K S S A Y L F H I VCNH A F L DGN KR T GA A A T L I
- - - T L MDMA A A Y GY H L C N N H P F I D GN K R I A L V AMD V
- - - D L VG L T A S L A YG L ARNH P F VDGN KR T AH VC YR V
- - - S T F D K A S A Y L F H I VCNH A F L DGN KR T GA A A T L I
- - - D L V E L T A S L A YG F ARNH P F VDGN KR T AH VC YR V
- - - - I F K L A A T YGYG F T KNHC F VDGN KR I A L A A V S V
- - - T I F KMA A T Y G F H L C N N H P F I D GN K R I S L V AMD I
- - - E V F D L A A A Y A F G L ARNH A F VDGN KR T A I V A A A T
- - - S V F D L A A A Y A YG I I RNH P F VDGN KR T G F L A A Y V
- - - S LWL K A A F V L QK S T K KH I F T DGN KR T A Y V V T K L
- - - D V I H L A A A Y T AG I L QNH P F VDRN KR T G F V VGV L
- - - D I F D L A A A Y L F G I L KNH P F I DGN KR T G L A A AD L
- - - D I F D L A A A Y L F G I L KNH P F I DGN KR T G L A A AD L
- - - D I F D L A A A Y L F G I L KNH P F I DGN KR T G L A A AD L
- - - S V F D L A A S Y A YG I I RNH P F VDGN KR T G F L A A Y V
- - - S L F D L A A A Y A YG I I RNH P F I DGN KR T G F L A A Y V
- - - S I P A I A A A Y L F H VCQNH A F VDGN KR VGAN A A I T
- E P I P T V F E L A A A F A F V KNH S F I DGN KR V A F V SMA T
- - - S V F D L A A A Y A YG I I RNH P F VDGN KR T G F L V A Y V
- - - D L A A P T A S L A YG L ARHH P F VDGN KR T A A V AC E T
- - - D L A A P T A S L A YG L ARHH P F VDGN KR T A A V AC E T
- - - - L P E L A A A Y A YG I ARNH P F VDGN KR T S L L A L Y T
S A SD A A A L A A A Y A YG I A KNH P F VDGN KR T S F V VC E L
- - - D I F L L A A T Y T SG I L QNH P F VDGN KR T G F V I GV L
- - - - L P E L A A A Y A F G L A K NH A F V DGN K R I A FMAM T V
E A P D F A A L A A S Y T V G L A K NH P F V DGN K R A A F L A T G L
- - - - - - - L A A S Y GY G I S RNH S F V DGN K R T G F V A L E L
- - - D L F AMA A A Y A F H I A QNQP F V DGN K R T G L L A A I V
- - - - L A E L A A A Y A F G L A K NH A F V DGN K R I A FMA L MV
- - P D A A T L A A A Y A Y G L A R N H G F A D GN K R T AWV V A R L
- - - D I Y EMA A A Y L F H L V RNH P F L DGN K R V GA V S A I V
- - - D I C EMA V A Y A F H I S K NH P F V DGN K R T A L V S A L V
- - A D A A A L A A A Y A Y G L A R N H G F A D GN K R T AWV V A R L
- - - S V F D L A A A Y A Y G I I RNH P F A DGN K R T G F L A A Y V
- - P S V HR L A A A CGV G L A RNH S Y RGGN K R T A FMAMY V
- P P D T A T L A A A Y A Y G I A R N H P F N D A N K R T AWS C C V L
- V DD V V E L A A T Y A V A V S S NH P F V DGN K R A A F H AM T L
- - - - MA A L A A A Y A F G L A RNH P F V DGN K R I A F L SMV A
- - - D L F EMA A A Y I F Y I CQDH P F V DGN K R T A L A T G L V
- - - - I QD I A A A Y A F G I A K A H A F V DGN K R T A F V A C A T
- D A D V F E I A A C Y A F A F T RNH P Y I DGN K R I A F HC A H A
- - - - I P QM A A A Y A E A I V R A H P F S D GN K R S G F L V A V V
- - - - L V DMA A A Y A F G I S K GHG F V DGN K R T A F V T A I T
- - - - L E E L S A A Y A F G I V K A H A F I DGN K R T A F V T A I T
- - - - L E E L A A S C A F G I T K A H A F I DGN K R T A F V T A V T
- - - EM T D K A A A L F E A I I R L K P F P V GN L A F A F I L T V L

- - - - - - - - -

a a a y a

g

n h p f

d gN k r t a

a

130

F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F
F

140

- - - - - - - - - - - - - - - - - - - - - - E - - - - 130
140
L L YN E Y E L K - MS EQE A SD F T VN V V EQR L
L VMN GY E L T - N D QV E L E R F T V A I A T D Y L
L K L NGY S L K - MENQE V VG F V V K I A T YQG
L QL NNCPVA - FSRQEAVD F I I M I T TSS L
L QL NGYD FQ - L D TQEGVD L L V F I A TYRS
L Q L N GY R F S - V T V E E A V KMC V T I A V E A L
L D L NGYE F TMTNK E A ED F TMY L V EDA K F
L K L N S I N F E - C T QD E A VQ F T L R V VND KN
L QL NGYR FS - V TVEEAVKCV - - - - - - - L K R N S Y H L K - C SWK E L A D Y T L S I A Q V D D
L S QN D C KMK - Y DMR E F E EMV C R V A QG L F
L QRNGY E I V - A S E K E T Y K I M I K L S AGQ L
L L L N G A E L I - A S Q E E K Y V A MMR L A D G AW
L S QN D C K I K - Y DMR E F E EMV C K V A QG L F
L L L N G A E L I - A S Q E E K Y V A MMG L A D G AW
L R I NGYE L N - ASEEEAAR F F L E L ASKVE
L QR N GY E I V - A T E K E T Y K T I MQ L S T GN L
L L L NGYRMT - ADDGA V Y A F TMA L A AGE I
L H M N GWQ L K - S S E A E A I N A I L N L A A G E V
L K L NGY S L K - V S K SQG I A L M L S V T T S AD
L E L NGYR F T - AAEEDSAQAV I A L AAGS L
L Y FNGYS L E - A EQEDV I QL V LMV T T S E I
L Y FNGYS L E - A EQEDV I QL V LMV T T S E I
L Y FNGYS L E - A EQEDV I QL V LMV T T S E I
L N I N GWQ L K - S S E A E A V N A V V D L A A G K I
L N I N GWE L M - L S E A E A I N A V L A L A A G E M
L L M N GWE P D - F E P D E L A D L V L S V A S G V I
L I L NGYS L E - VPEEEVV LM I KR L S TDQE
L H I N GWE L R - S I E V E A V N A V L D L A A G E M
I V L NGA T L L - AGD L E L YG F Y I G L ADGSH
I V L NGA T L L - AGD L E L YG F Y I G L ADGSH
L GVNGFD FD - VPEADAAAV I L A L AAGEV
L A L N GY D L T - MD D A T A V T TWL A L A A S E L
L E L NGYK F I - ANEEDSAQA I I S L AEGS L
L TKNAVA FD - PDPAQS TS I I L S L AAGEV
L Y L NGYR L N - A SQADA T L TMF A V A SGE I
L A L NGY D L T - A T D A DC V L I M L S V A A GD I
L D L NG I P I S - D P AGR L YD AM I A V A ERRM
L TKNGVA FD - PSAAHS TS I I L S L AAGEV
L V DNGY R L QGV D K R E A V R I V E A I A GGS L
L A L NGYD F E - A P END L V EMV YGV AR S E F
P E L NG I S I S - D S QGK L Y D AM L D L S T GK L
L ADNGYR L K - FD P AD A VR TMEMV A AGA L
L H S N GWE L R - A R E A E A V H V V L A L A A G E M
L R L N GP R I D - V E EMA V V D L MR S V A QS D G
L R L NGTR VQ - VGA P E A V E AMV A L A SGAM
L R L NGL R L V - ADQADAAR T I FK L AAGE L
L RMN D I S F A - P D P GQA T S I I L S L A A GE V
L E L NGV T I T - D S KG I L Y T A VME L V ARN I
L R L N GWS L R - P D P A E G V R MM E D L A A S R V
L Y L N GW I L R - A P Q P E V V F Q V L A L A E G Q L
L G L NG F S F Q - A S N E S V V L M I QR L A A GD L
L R L NGY A F R - P E P V DGV R L ME D L A A GQ I
L R L N D L V F R - P D P V G G V QMM E G L A A G T V
L R L N G V A F R - P D A A E G V R MM E G L A A D A V
I H K N GWR L N - A S D D E V R Q F L K N F S E G V R

F l

l Ng

-

e

l a

g

Figure toxins members of the TasAB family members
Putative 3
Putative toxins members of the TasAB family members. Multiple alignments of the putative toxins related to the TasB
toxin of pGI1 from B. thuringiensis H1.1. Only TasB-like proteins with obvious upstream TasA-like partners (see Fig. 4) were
included in this comparison. The left column shows the bacterial host of the protein. Fully conserved amino acids are in dark
grey while the other most conserved residues (>50%) are shown in light grey. Variations observed in the TasB mutants recovered from cloning in E. coli are displayed at the top line of the alignment. Many are point mutations (square) and other are early
stops (triangle). The consensus sequence is displayed in the last line of the pile-up.
putative antitoxin TasA. These loci were also found in a
large variety of microorganisms including 35 proteobacteria, 10 actinobacteria, 8 firmicutes, 4 archaea, 2 cyanobacterium, 1 chloroflexi, 1 chlamydiae and 1 phage (P1). All
are chromosomal loci, except for one that was found in
the pCC7120epsilon plasmid of Nostoc sp. PCC 7120 and
one found on the pKLH205 plasmid of Acinetobacter sp.
ED-4525. The upstream ORFs were compared to the Conserved Domain Database (CDD) [22] and classified
according to their similarities with other published
sequences or with other upstream genes found in this
analysis (see Additional file 3). By this classification, 10
groups of composite TA loci were obtained (Fig. 4).
In the first group (group 1), which was composed of 5
loci, one of the TasB homologues was a confirmed toxin
from the known phd-doc TA locus of enterobacterial phage
P1 [5]. All the systems included in this group harboured
an upstream ORF similar (identity > 39%) to the Phd antitoxin of the phd-doc system. This group was thus composed of loci displaying similarities to both the TasB/Doc

toxins and the Phd antitoxin. The 5 members of this group
were all similar in size and organization (translation coupling). The second group (group 2) was composed of five
TA loci (identity > 44%) that were all found in Î³-proteobacteria. All antitoxins of this group were very similar in
size except for the one found in Ps. aeruginosa, which was
smaller than the others. It is also interesting to note that
in the putative toxin gene of the Ps. aeruginosa TA locus,
two frameshifts give rise to a hybrid protein. Group 3 of
composite TA systems included small antitoxins (identity
> 66%). However, in two cases, Vibrio cholerae O1 eltor
N16961 and in V. cholerae V52, the putative antitoxin
seemed to be fused at its amino-terminal part with a putative acetyl-transferase (not shown). In the next 6 groups
(groups 4 to 9), all upstream proteins were similar to each
other within a group (identity > 38%), but shared no similarities with other known proteins. The last group (group
10) was composed of 2 members (100% identical) from
the same organism delta proteobacterium MLMS-1. They
were larger than tasA and contained a domain similar to

Page 6 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

http://www.biomedcentral.com/1471-2164/7/259

$


 ORFL



 ORFL



 ORFL



 ORFL



 ORFL



 ORFL



 ORFL



 ORFL



 ORFL



GRF

SKG

WDV%

WDV$



PD](

 ORFL

 ORFL

PD])

 ORFL



&2*

 ORFL



&2*

 ORFL



3,1

 ORFL

Figure of
Groups 4 loci whose corresponding proteins show similarities with TasA and/or TasB
Groups of loci whose corresponding proteins show similarities with TasA and/or TasB. Schematic representation
of the genomic locations of TasB homologues and their associated upstream ORF, and genomic locations of TasA homologues
and their associated downstream ORF. Associated upstream- and downstream genes were grouped according their similarities
when blasted against the Conserved Domain Database (CDD). The number of the group (see text for details) is indicated in
the left column. The number of loci composing each group is indicated in the right column. Known domains are indicated inside
the arrow of the corresponding group.

that of ParB, which has been proposed to be a nuclease
involved in plasmid stability [23].

similarity to TasA or to other known genes. It is possible
that new groups of antitoxins could be discovered.

In addition to these 10 groups, a number of orphan
upstream genes were found (see Additional file 2). These
genes were predicted to code for proteins displaying no

Furthermore, nine TasB homologues, all originating from
the proteobacteria phylum, were found to be significantly
larger than the others (see Additional file 2). While the

Page 7 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

carboxy-termini of the corresponding proteins were similar to the pGI1 TasB toxin, their amino-termini displayed
similarity with the COG3943 domain. This domain is
defined in the Conserved Domain Database as related to
a virulence protein because of its similarities to RhuM.
This protein, located in the SPI-3 pathogenicity island of
S. enterica [24], is predicted to be a virulence protein
because mutants carrying a knocked out copy exhibit
diminished ability to invade epithelial cell and/or to
induce polymorphonuclear leukocyte migration in a tissue culture model of mammalian enteropathogenesis
[25]. In this group, no upstream antitoxin seemed to be
associated with these putative toxins.
Finally, 10 TasB homologues were defined as "solitary
toxin" [26], since they had the same size as TasB but were
apparently not associated with an antitoxin partner (not
shown). These solitary toxins were found in a broad range
of microorganisms including 4 proteobacteria, 2 actinobacteria, 2 archaea, 1 fusobacterium and even 1 fungus.
The latter was found in Aspergillus fumigatus. This gene has
been annotated as a putative member of the Doc family
([GenBank:EAL85381], Nierman et al., unpublished), but
the exact function of the protein has not been demonstrated. If this homologue were proved to be functional,
this would be the first TA locus identified in a fungal species.
Similar cases of solitary genes have already been reported
in the study of homologues of the YdcE toxin (MazF family) from the ycDE operon of Bacillus subtilis [27], in a
study describing a number of TA loci from the vapBC family (vapC is a toxin containing a PIN domain) [28] and in
an exhaustive study of TA homologues [26]. This suggests
that if those solitary toxins were found to be functional,
other mechanisms of regulations specific to each species
would have to exist.
TasA homologues can be associated with either TasB homologues or
with other toxin families
As in the case of the TasB toxin, the TasA antitoxin of pGI1
was compared to potential downstream ORFs for their
similarities and putative functions. Homologues of the
TasA antitoxin found in this study were separated into
three classes: those with a TasB-like downstream gene as
described above (Fig. 2 and Fig. 4), the second including
TasA homologues with a toxin-like downstream gene (Fig.
4), and TasA homologues not associated with a putative
toxin.

Homologues of TasA associated with proteins unrelated
to TasB were found in 15 archaea, 6 proteobacteria, 4 firmicutes and 1 spirochaete (see Additional file 2). Downstream proteins of TasA homologues were grouped
according to their similarities (see Additional file 3); four

http://www.biomedcentral.com/1471-2164/7/259

groups of composite TA loci were obtained (see Additional file 2). The first group (group 11) was composed of
6 TA loci (identity > 27%) very similar in size, originating
from phylogenetically distant species, and all sharing similarities with the mazF toxin of the confirmed TA locus
mazEF. This high similarity between TasB and the Doc
toxin (28% identity ; E-value = 2e-19 in the CDD), combined with the similarity between TasA and the MazE antitoxin (23% ; E-value = 2e-3 in the CDD), indicated that
the tasA-tasB toxin-antitoxin system from pGI1 is thus a
composite mazE-doc-like system. In the second group
(group 12), 12 TA loci were found (identity > 27%). The
putative toxins downstream of the TasA-like genes were all
similar in size, except for the one originating from Pyrococcus horikoshii, smaller than the others and than the TasB
toxin from pGI1. All the putative toxins found in this
group belonged to the conserved domain COG1848. Proteins of this group are predicted nucleic acid-binding proteins, containing a PIN domain. The PIN (PilT Nterminus) domain was first annotated on the basis of
sequence similarity to the N-terminal domain of the pilT
protein from Myxococcus xanthus [29]. Proteins containing
such a domain can be found in the genome of a large variety of prokaryotes and eukaryotes. By analogy with
eukaryotic PIN proteins, which are ribonucleases [30],
prokaryotic PIN proteins have been predicted to be toxic
components of chromosomally encoded TA operons [31].
The vapBC locus of Leptospirra interrogans has been
described as a toxin-antitoxin system in which the VapC
toxin contains a PIN domain [32].
Both loci of the next group (group 13) harboured a conserved domain COG5573. This group is related to the
COG1848 group and also contains a PIN domain. The last
group (group 14) contained 3 loci of which the downstream proteins belonged to the pfam01850 group, also
harbouring a PIN domain. These 3 groups were thus considered to be functionally related as they all contained a
PIN domain. In addition to these groups, three orphan
cases of composite TA loci were found in which the associated toxin showed no similarity with other toxins (see
Additional file 2).
In addition to those found above, a number of TasA
homologues were found for which no gene could be identified immediately downstream of their genomic location
(not shown). These genes were often longer than the antitoxin of pGI1. Only the N-part of the protein displayed a
high degree of homology with the antitoxin. These homologues have been annotated as transcriptional regulator of
the AbrB- and SpoVT-family. Comparison with the CDD
(Conserved Domain Database, NCBI) showed that they
all harboured a SpoVT/AbrB-like domain [22]. The product of the AbrB gene is an ambiactive repressor and activator of the transcription of genes expressed during the

Page 8 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

transition state between vegetative growth and the onset
of stationary phase and sporulation [33]. AbrB is thought
to interact directly with the transcription initiation
regions of genes under its control [34]. The product of the
B. subtilis gene spoVT is another member of this family and
is also a transcriptional regulator [35].
It has been shown that antitoxins contain motifs common
to different classes of DNA-binding proteins and can
therefore be classified according to their structural homologies: MetJ/Arc superfamily and related ribbon-helix-helix
fold proteins, Phd/YefM and AbrB/MazE superfamilies
[36]. Multiple alignments of the TasA homologues
showed a highly conserved amino-terminal domain (Fig.
2). This was consistent with other studies that have used
mutational analyses to show that antitoxins bind to DNA
through their N-terminal domain [3].

Conclusion
In this work, we showed that the pGI1 plasmid of B. thuringiensis H1.1 encodes a new toxin-antitoxin system,
called tasA-tasB for thuringiensis addiction system. This system appeared to be functional in E. coli, and a single mutation in the tasB gene was sufficient to inhibit the lethal
activity of the toxin in E. coli. However, the addition of a
plasmid containing the tasA gene failed to restore the viability of the cells, probably due to an inappropriate
expression in the Gram-negative background.
Additionally, our study revealed a new family of TA loci,
the TasAB family which is presently composed of at least
56 members, found in a large variety of microorganisms.
TA systems have been extensively described and their toxins have been classified into superfamilies, according to
their structural homologies: the MazF/Kid/CcdB, the
RelE/ParE, the Doc and the PIN superfamilies [36]. In the
TasAB family, exhaustive protein sequence searches
showed that the TasB toxin of the tasAB system from pGI1
is similar to Doc of the phd-doc system. Interestingly, TasA
was not similar to the antitoxin Phd, but presented similarities with the MazE antitoxin from the mazEF TA system. The tasAB system and members of its family can thus
be viewed as hybrid systems between the phd-doc and the
mazEF systems. Moreover, other associations between toxins and antitoxins from different families can be found, as
illustrated in our extensive protein search which showed
that TasA and TasB homologues can be found in association with partners from other TA systems.
The present study confirmed that more than multiple TA
systems can be found in the same bacterium. In the Sulfolobus solfataricus genome for exemple, 22 TA loci, all
from the vapBC family (vapC is a member of the PIN
domain family) have been found [28]. Interestingly,
microarray experiments have revealed the implication of

http://www.biomedcentral.com/1471-2164/7/259

these TA loci in the heat shock response, which involves
the modulation of their expression under stress conditions [28]. Since TA system could be stress-response elements, it has been suggested that free-living organisms,
which grow slowly and are exposed to many environmental changes in comparison to host-associated organism,
would benefit from having many TA loci [26].
There seems to be a common organization within the TA
systems, featuring two genes, one coding for a toxin and
the other coding for a DNA-binding protein that functions
as an antitoxin and a transcription factor. Because composite associations of different toxins and antitoxins were
found, it has been suggested that TA systems do not
descend from a common ancestor but have been assembled from different proteins which can be displaced by
functional equivalents, while the operon architecture
itself is preserved [36]. Consistently with this idea, ORF of
unknown function associated with a TasB homologue
could potentially represent members of new antitoxin
families.

Methods
Bacterial strains, plasmids and growth conditions
Table 1 reports the bacterial strains used in this study,
including their origin, reference and main characteristics.
The B. thuringiensis and E. coli strains were grown on LuriaBertani (LB) broth, at 30Â°C and 37Â°C, respectively.

The primary cloning of the toxin and antitoxin genes was
performed using the kanamycin-resistance, positive-selection plasmid vector pCR4-TOPO (InVitrogen), and electroporated into E. coli TOP10 strain. The antitoxin gene
was subsequently cloned in the ampicillin-resistance plasmid pCYB10 and the toxin gene in the chloramphenicolresistance plasmid pBAD33 (see PCR and cloning strategies). Newly constructed plasmids were electroporated in
E. coli TG1 strains. The antibiotics were used at the following concentrations: 50 Âµg/ml kanamycin (Kan), 100 Âµg/
ml ampicillin (Amp), and 15 Âµg/ml chloramphenicol
(Cm).
DNA preparation
Total DNA from B. thuringiensis H1.1 was prepared using
standard protocol and stored at -20Â°C. Plasmid DNA
preparations were obtained using the High Pure Plasmid
Kit (Roche).
PCR and cloning strategies
Cloning fragments of the toxin-antitoxin system from pGI1 of B.
thuringiensis H1.1 in pCR4-TOPO
Table 2 shows the oligonucleotide primers (purchased
from Sigma-Genosys) used in the PCR method for cloning
different gene fragments of the toxin-antitoxin system
from pGI1 of B. thuringiensis H1.1. One pair of primer

Page 9 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

http://www.biomedcentral.com/1471-2164/7/259

Table 1: Strains and plasmids. Strains and plasmids used in this study, including their origin, reference and main characteristics

Strains or plasmids
Strains
B. thuringiensis H1.1
E. coli TOP10
E. coli TG1
Plasmids
pGI1
pCR4-TOPO
pCYB1
pCYB10
pBAD33
pGIF02
pGIF03
pGIF04Mx
pGIF06Mx
pGIF08M1
pGIF10Mx

Relevant features

Construction, source or reference

Isolated from Ephestia kÃ¼hniella, Canada

IEBC (International Entomopathogenic Bacillus Center,
Pasteur Institute, Paris, France)
InVitrogen
Gibson, 1984

Cloning host
Cloning host
Resident plasmid from B. thuringiensis H1.1
Positive-selection cloning vector, AmpR, KanR
Cloning vector, AmpR, IPTG-inducible ptac promoter
pCYB1 deleted of intein gene
Cloning vector, CmR, arabinose-inducible promoter pBAD
PCR fragment containing antitoxin gene of pGI1 cloned into
pCR4-TOPO
NdeI-SalI pGIF02 fragment containing the antitoxin gene A
cloned into pCYB1O
PCR fragment containing the toxin gene P cloned into pCR4TOPO, 4 clones obtained M1 â M4
PCR fragment containing the antitoxin-toxin locus AP cloned
into pCR4-TOPO, 4 clones obtained M1 â M4
PCR fragment containing the antitoxin-toxin locus pAP cloned
into pCR4-TOPO
PCR fragment containing the antitoxin-toxin locus p2AP cloned
into pCR4-TOPO, 15 clones obtained M1 â M15

amplified the toxin gene only (P), while another pair
amplified a region from the start of the antitoxin gene to
the stop of the toxin gene (AP). A third pair flanked the
toxin and antitoxin genes with an upstream region
thought to contain the promoter region (pAP). Finally,
the last pair of primers amplified an additional 78 bp
region upstream of the antitoxin gene (p2AP) (Fig. 1B).
One Âµl of total DNA (50-fold dilution) of B. thuringiensis
H1.1 was used for the amplification of the gene fragments

Mahillon and Seurinck, 1988
InVitrogen
New England Biolabs Inc.
J. Mahillon and F. Bilocq unpubl. results
Guzman et al., 1995
This study
This study
This study
This study
This study
This study

in a 50 Âµl mixture containing 1 Âµl of DyNAzyme I DNA
polymerase (FINNZYME), 5 Âµl of the 10 Ã standard
buffer, 0,5 Âµl dNTP (20 mM) and 5 Âµl primers (10 ÂµM).
The reaction was performed in a Perkin Elmer GeneAmp
PCR System 9600 thermal cycler using the following program: initial denaturation at 96Â°C for 10 min, 30 cycles of
denaturation at 92Â°C for 1 min, annealing for 1 min at
50Â°C and extension at 72Â°C for 1 min 30 sec. An addi-

Table 2: Oligonucleotide primers. Oligonucleotide primers used in PCR assays to clone different segments of the toxin-antitoxin
system from pGI1.
Segment

Region amplified (Accession
number : AY138809)a

Oligonucleotide primersb

Primer
names

Length (bp) of amplified region

A

(304â629)C
(8147â8254,1â332)C

AP

(8147â8254,1â629)C

pAP

(8147â8254,1â861)C

p2AP

(8147â8254,1â939)C

RTA

(370...630)C

RTP

(8249â8254,1â228)C

RTAP

(8249â8254,1â630)C

DOTF
DOTR2
pOIf
pOIr
DOTF
pOIr
ValC
pOIr
ValC2
pOIr
RTAf
RTAr
RTPf
RTPr
RTAf
RTPr

345 bp

P

5'-TTAGGCATATGACAGCAAACACTCGCCACATGG-3'
5'-AATATGTCGACTCATTTCGGTTTTCCTACTTTCCTCC-3'
5'-GGCCCGGTACCGTGGAGGAAAGTAGGAAAACCG-3'
5'-CCCGTCGACCCCACGTCTTTTTTTAATTTAAAGG-3'
5'-TTAGGCATATGACAGCAAACACTCGCCACATGG-3'
5'-CCCGTCGACCCCACGTCTTTTTTTAATTTAAAGG-3'
5'-AACGGTTAATACGTTCTAACTG-3'
5'-CCCGTCGACCCCACGTCTTTTTTTAATTTAAAGG-3'
5'-GGCTCTAGAATCTTCCCTATC-3'
5'-CCCGTCGACCCCACGTCTTTTTTTAATTTAAAGG-3'
5'-AATGACAGCAAACACTCGCC-3'
5'-GCACCGTCAAATTTATTGATGG-3'
5'-GAGGTGTTAAAGATACAGG-3'
5'-AATCTGAAGCTTCTTGTTCGG-3'
5'-AATGACAGCAAACACTCGCC-3'
5'-AATCTGAAGCTTCTTGTTCGG-3'

459 bp
754 bp
978 bp
1056 bp
261 bp
234 bp
636 bp

a: C indicates complementary sequences.
b: Letters in bold refer to restriction sites.

Page 10 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

tional extension step for 10 min at 72Â°C ends the amplification program.
The PCR products were ligated into the plasmid vector
pCR4-TOPO using the protocol described in the TOPO TA
cloning Kit for sequencing (InVitrogen) and transformed
by electroporation into E. coli TOP10. Inserts from the
KanR recombinants were sequenced by Genome Express
(France) using the M13 universal primers.
Cloning of the antitoxin gene in pCYB10
The pCR4-TOPO plasmid containing the A fragment (Fig.
1B), obtained as described above, was sequenced to assess
the absence of any mutation, and called pGIF02. Both
pGIF02 (KanR, AmpR) and pCYB10 plasmids (AmpR)
were restricted by NdeI and SalI enzymes. After extraction
on gel using Quantum Prep Freeze'N Squeeze DNA Gel
Extraction Spin Column (Biorad), the restricted fragments
were ligated using 2 units of T4 DNA ligase (Fermentas, T4
DNA ligase Rapid ligation kit). The newly constructed
plasmid, pGIF03 obtained in E. coli TG1 was sequenced
by Genome Express (France).
Bioinformatics
Search for TasA and TasB homologues
The amino acid sequence of the putative TasB toxin was
compared
using
standard
BLASTP
http://
www.ncbi.nlm.nih.gov/BLAST. The cut-off E-value used
in this analysis was 1. The genomic regions carrying
potential toxin homologues were analyzed individually
using DS Gene 1.5 (Accelrys), in order to find any
upstream ORF. The same method was applied to the TasA
antitoxin of pGI1 from B. thuringiensis H1.1, to find
potential downstream partners. All the loci found in this
computational study are listed in the Additional file 1.
Classification of putative toxins and antitoxin partners
Each immediate upstream ORF of TasB homologue, and
downstream ORF of TasA homologue were translated in
silico, using DS Gene 1.5, and compared to the Conserved
Domain Database [22] in order to search for similarity
with other known antitoxins/toxins from TA systems or
with other known proteins. Identity percentages were calculated within a group by using NCBI/BLAST/
align2sequences.

http://www.biomedcentral.com/1471-2164/7/259

Additional material
Additional File 1
Accession numbers. Accession number of all proteins (TasB homologues,
TasA homologues, and their associated proteins) are listed in this table.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-7-259-S1.pdf]

Additional File 2
Genetic organization of genomic loci whose corresponding proteins
show similarities with TasA and/or TasB. Detailed and scaled representation of genomic loci harbouring a tasA and/or a tasB homologue. The
bacterial hosts of the loci are indicated in the right column, together with
the taxonomic groups they belong to. On the left, "P" indicates that the
locus is found on a plasmid; others are chromosomal loci. Genes whose
corresponding proteins show similarities with both TasA antitoxin and
TasB toxin of pGI1 are shown in green and pink, respectively. The upper
part of the scheme shows a scaled representation of the genomic locations
of TasB homologues (in pink) and their associated upstream ORF. Based
on their putative antitoxin similarities, these TA loci could be classified
into 10 groups shown with distinct colours. Genes in white are orphan
genes whose corresponding proteins share no similarity with other known
proteins. In several cases, larger genes encode proteins whose C-terminal
ends are unrelated to the TasA antitoxin, but display similarities with a
putative virulence protein (grey). The dashed red box in the toxin of Ps.
aeruginosa refers to a double frameshift (see text for details). The middle
part of the picture indexes all members of the TasAB family, where all loci
harbour homologies with both TasA and TasB. The lower part of the figure
shows a scaled representation of the genetic organization of tasA homologues and their associated downstream ORF. These putative TA systems
are displayed as 4 groups on the basis of their putative toxins. Genes in
white are orphan genes whose corresponding proteins do not share significant similarities with other proteins.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-7-259-S2.pdf]

Additional File 3
Alignments of groups of upstream- and downstream proteins of TasB
and TasA homologues. Bioinformatics analyses yielded 10 groups of
upstream proteins and 4 groups of downstream proteins (see text for
detail). Alignments of each group (1 to 14) are represented in this figure.
The names of the strains where these loci were found are indicated in the
left column. The consensus sequence is displayed in the last line. Fully conserved amino acids are in dark grey while the other most conserved residues (>50%) are shown in light grey.
Click here for file
[http://www.biomedcentral.com/content/supplementary/14712164-7-259-S3.pdf]

Authors' contributions
SF carried out the molecular genetic studies and the bioinformatics analyses, participated in the design of the study
and drafted the manuscript. JM conceived of the study,
and participated in its design and coordination and
helped to draft the manuscript. All authors read and
approved the final manuscript.

Acknowledgements
We are grateful to F. Bilocq and V. Op de Beek for initiating this project.
We would like to thank L. Van Melderen for time devoted to the critical
reading of this manuscript. We are also grateful to G. Van der Auwera for
her help for the figure and time devoted to the proofreading of the manuscript, and to O. Minet for his technical help. This work was supported by
the Region Wallonne (Convention nÂ°991/4383), the FRIA (Fonds pour la
Formation Ã  la Recherche dans l'Industrie et dans l'Agriculture) (grant to S.
Fico) and the UniversitÃ© catholique de Louvain.

Page 11 of 12
(page number not for citation purposes)

BMC Genomics 2006, 7:259

References
1.
2.
3.
4.
5.

6.
7.
8.
9.

10.
11.

12.
13.
14.
15.
16.

17.

18.

19.
20.

21.
22.

Nordstrom K, Austin SJ: Mechanisms that contribute to the stable segregation of plasmids. Annu Rev Genet 1989, 23:37-69.
Hiraga S: Chromosome and plasmid partition in Escherichia
coli. Annu Rev Biochem 1992, 61:283-306.
Gerdes K, Christensen SK, Lobner-Olesen A: Prokaryotic toxinantitoxin stress response loci. Nat Rev Microbiol 2005, 3:371-382.
Jensen RB, Gerdes K: Programmed cell death in bacteria: proteic plasmid stabilization systems.
Mol Microbiol 1995,
17:205-210.
Lehnherr H, Maguin E, Jafri S, Yarmolinsky MB: Plasmid Addiction
Genes of Bacteriophage P1: doc, which Causes Cell Death on
Curing of Prophage, and phd, which Prevents Host Death
when Prophage is Retained. Journal of Molecular Biology 1993,
233:414-428.
Lehnherr H, Yarmolinsky MB: Addiction Protein Phd of Plasmid
Prophage P1 is a Substrate of the ClpXP Serine Protease of
Escherichia coli. PNAS 1995, 92:3274-3277.
Gazit E, Sauer RT: The Doc Toxin and Phd Antidote Proteins
of the Bacteriophage P1 Plasmid Addiction System Form a
Heterotrimeric Complex. J Biol Chem 1999, 274:16813-16818.
Magnuson R, Lehnherr H, Mukhopadhyay G, Yarmolinsky MB:
Autoregulation of the Plasmid Addiction Operon of Bacteriophage P1. J Biol Chem 1996, 271:18705-18710.
Wawrzynow A, Wojtkowiak D, Marszalek J, Banecki B, Jonsen M,
Graves B, Georgopoulos C, Zylicz M: The ClpX heat-shock protein of Escherichia coli, the ATP-dependent substrate specificity component of the ClpP-ClpX protease, is a novel
molecular chaperone. EMBO J 1995, 14:1867-1877.
Wang J, Hartling JA, Flanagan JM: The structure of ClpP at 2.3 A
resolution suggests a model for ATP-dependent proteolysis.
Cell 1997, 91:447-456.
Grimaud R, Kessel M, Beuron F, Steven AC, Maurizi MR: Enzymatic
and Structural Similarities between the Escherichia coli
ATP-dependent Proteases, ClpXP and ClpAP. J Biol Chem
1998, 273:12476-12481.
Engelberg-Kulka H, Glaser G: Addiction modules and programmed cell death and antideath in bacterial cultures. Annu
Rev Microbiol 1999, 53:43-70.
Engelberg-Kulka H, Sat B, Hazan R: Bacterial Programmed Cell
Death and Antibiotics. ASM News 2001, 67:617-624.
Engelberg-Kulka H, Sat B, Reches M, Amitai S, Hazan R: Bacterial
programmed cell death systems as targets for antibiotics.
Trends Microbiol 2004, 12:66-71.
Lewis K: Programmed Death in Bacteria. Microbiol Mol Biol Rev
2000, 64:503-514.
Aizenman E, Engelberg-Kulka H, Glaser G: An Escherichia coli
chromosomal "addiction module" regulated by guanosine
[corrected] 3',5'-bispyrophosphate: a model for programmed bacterial cell death. Proc Natl Acad Sci U S A 1996,
93:6059-6063.
Sat B, Hazan R, Fisher T, Khaner H, Glaser G, Engelberg-Kulka H:
Programmed Cell Death in Escherichia coli: Some Antibiotics Can Trigger mazEF Lethality.
J Bacteriol 2001,
183:2041-2045.
Andrup L, Jensen GB, Wilcks A, Smidt L, Hoflack L, Mahillon J: The
patchwork nature of rolling-circle plasmids: comparison of
six plasmids from two distinct Bacillus thuringiensis serotypes. Plasmid 2003, 49:205-232.
Mahillon J, Seurinck J: Complete nucleotide sequence of pGI2, a
Bacillus thuringiensis plasmid containing Tn4430. Nucleic Acid
Res 1988, 16:11827-11829.
Hoflack L, Seurinck J, Mahillon J: Nucleotide sequence and characterization of the cryptic Bacillus thuringiensis plasmid
pGI3 reveal a new family of rolling circle replicons. J Bacteriol
1997, 179:5000-5008.
Afif H, Allali N, Couturier M, Van Melderen L: The ratio between
CcdA and CcdB modulates the transcriptional repression of
the ccd poison-antidote system. Mol Microbiol 2001, 41:73-82.
Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C,
Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ,
Liebert CA, Liu C, Lu F, Marchler GH, Mullokandov M, Shoemaker
BA, Simonyan V, Song JS, Thiessen PA, Yamashita RA, Yin JJ, Zhang D,
Bryant SH: CDD: a Conserved Domain Database for protein
classification. Nucl Acids Res 2005, 33:D192-196.

http://www.biomedcentral.com/1471-2164/7/259

23.
24.
25.

26.
27.

28.

29.
30.
31.
32.

33.

34.

35.
36.

Johnson EP, Mincer T, Schwab H, Burgin AB, Helinski DR: Plasmid
RK2 ParB Protein: Purification and Nuclease Properties. J
Bacteriol 1999, 181:6010-6018.
Blanc-Potard AB, Solomon F, Kayser J, Groisman EA: The SPI-3
pathogenicity island of Salmonella enterica. J Bacteriol 1999,
181:998-1004.
Tenor JL, McCormick BA, Ausubel FM, Aballay A: Caenorhabditis
elegans-based screen identifies Salmonella virulence factors
required for conserved host-pathogen interactions. Curr Biol
2004, 14:1018-1024.
Pandey DP, Gerdes K: Toxin-antitoxin loci are highly abundant
in free-living but lost from host-associated prokaryotes.
Nucleic Acids Res 2005, 33:966-976.
Pellegrini O, Mathy N, Gogos A, Shapiro L, Condon C: The Bacillus
subtilis ydcDE operon encodes an endoribonuclease of the
MazF/PemK family and its inhibitor. Mol Microbiol 2005,
56:1139-1148.
Tachdjian S, Kelly RM: Dynamic metabolic adjustments and
genome plasticity are implicated in the heat shock response
of the extremely thermoacidophilic archaeon Sulfolobus solfataricus. J Bacteriol 2006, 188:4553-4559.
Wall D, Kaiser D: Type IV pili and cell motility. Molecular Microbiology 1999, 32:1-10.
Clissold PM, Ponting CP: PIN domains in nonsense-mediated
mRNA decay and RNAi. Curr Biol 2000, 10:R888-90.
Arcus VL, Rainey PB, Turner SJ: The PIN-domain toxin-antitoxin
array in mycobacteria. Trends in Microbiology 2005, 13:360-365.
Zhang YX, Li J, Guo XK, Wu C, Bi B, Ren SX, Wu CF, Zhao GP:
Characterization of a novel toxin-antitoxin module, VapBC,
encoded by Leptospira interrogans chromosome. Cell Res
2004, 14:208-216.
Strauch MA, Spiegelman GB, Perego M, Johnson WC, Burbulys D,
Hoch JA: The transition state transcription regulator abrB of
Bacillus subtilis is a DNA binding protein. Embo J 1989,
8:1615-1621.
Robertson JB, Gocht M, Marahiel MA, Zuber P: AbrB, a regulator
of gene expression in Bacillus, interacts with the transcription initiation regions of a sporulation gene and an antibiotic
biosynthesis gene. Proc Natl Acad Sci U S A 1989, 86:8457-8461.
Bagyan I, Hobot J, Cutting S: A compartmentalized regulator of
developmental gene expression in Bacillus subtilis. J Bacteriol
1996, 178:4500-4507.
Anantharaman V, Aravind L: New connections in the prokaryotic
toxin-antitoxin network: relationship with the eukaryotic
nonsense-mediated RNA decay system. Genome Biol 2003,
4:R81.

Publish with Bio Med Central and every
scientist can read your work free of charge
"BioMed Central will be the most significant development for
disseminating the results of biomedical researc h in our lifetime."
Sir Paul Nurse, Cancer Research UK

Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published immediately upon acceptance
cited in PubMed and archived on PubMed Central
yours â you keep the copyright

BioMedcentral

Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp

Page 12 of 12
(page number not for citation purposes)

</pre>
</body>
</html>
